Nitric Oxide-GAPDH Transcriptional Signaling Mediates Behavioral Actions of Cocaine

Author(s): Maged M. Harraz, Solomon H. Snyder

Journal Name: CNS & Neurological Disorders - Drug Targets
Formerly Current Drug Targets - CNS & Neurological Disorders

Volume 14 , Issue 6 , 2015

Become EABM
Become Reviewer
Call for Editor


Psychotropic actions of cocaine are generally thought to involve its blockade of monoamine transporters leading to increased synaptic levels of monoamines, especially dopamine. Subsequent intracellular events have been less well characterized. We describe a signaling system wherein lower behavioral stimulant doses of cocaine, as well as higher neurotoxic doses, activate a cascade wherein nitric oxide nitrosylates glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to generate a complex with the ubiquitin-E3-ligase Siah1 which translocates to the nucleus. With lower cocaine doses, nuclear GAPDH augments CREB signaling, while at higher doses p53 signaling is enhanced. The drug CGP3466B very potently blocks GAPDH nitrosylation, hindering both signaling cascades and inhibits both behavioral activating and neurotoxic effects of cocaine. This system affords potentially novel approaches to the therapy of cocaine abuse.

Keywords: Addiction, CGP3466B, cocaine, GAPDH, neurotoxicity, nitric oxide, nitrosylation.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 23 June, 2015
Page: [757 - 763]
Pages: 7
DOI: 10.2174/1871527314666150529150143
Price: $65

Article Metrics

PDF: 27